Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients

Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients

Background: Molecular characterization is pivotal for managing non-small cell lung cancer (NSCLC), although this process is often time-consuming and patients’ conditions might worsen while molecular analyses are processed.Our primary aim was to evaluate the performance of “up-front” next-generation...

Full description

Saved in:
Bibliographic Details
Main Authors: Francesca Parisi, Giuseppa De Luca, Manuela Mosconi, Sonia Lastraioli, Chiara Dellepiane, Giovanni Rossi, Silvia Puglisi, Elisa Bennicelli, Giulia Barletta, Lodovica Zullo, Sara Santamaria, Marco Mora, Alberto Ballestrero, Fabrizio Montecucco, Andrea Bellodi, Lucia Del Mastro, Matteo Lambertini, Emanuela Barisione, Giuseppe Cittadini, Elena Tagliabue, Francesco Spagnolo, Marco Tagliamento, Simona Coco, Mariella Dono, Carlo Genova
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Lung cancer
Liquid biopsy
EGFR
Targeted therapy
Emergency department
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294224000510
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items